TURKU, FI / ACCESS Newswire / June 8, 2026 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN)Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS1a. Identity of the issuer or the underlying issuer of existing shares:Faron Pharmaceuticals Oy1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)Non-UK issuerX2. Reason for the notification (please mark the appropriate box or boxes with an "X")An acquisition or disposal of sharesAn acquisition or disposal of financial instrumentsAn event changing the breakdown of shares outstandingXOther (please specify):3. Details of person subject to the notification obligationNamePentwater Capital Management LPCity and country of registered office (if applicable)Naples, United States4. Full name of shareholder(s) (if different from 3.)NameCity and country of registered office (if applicable)5. Date on which the threshold was crossed or reached:04/06/20266. Date on which issuer notified (DD/MM/YYYY):05/06/20267. Total positions of person(s) subject to the notification obligation% of shares outstanding (total of 8. A)% of shares outstanding through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of shares outstanding held in issuerResulting situation on the date on which threshold was crossed or reached3.875746%3.875746%8,000,000.00Position of previous notification (ifapplicable)4.342441%4.342441%8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedvA: SharesClass/type ofsharesISIN code (if possible)Number of shares outstanding% of shares outstandingDirect Indirect Direct Indirect SUBTOTAL 8. AB 1: Financial Instruments as an entitlement to acquireType of financial instrumentExpirationdateExercise/ Conversion PeriodNumber shares that may be acquired if the instrument isexercised/converted.% of shares outstandingSUBTOTAL 8. B 1B 2: Financial Instruments with similar economic effectType of financial instrumentExpirationdateExercise/ Conversion PeriodPhysical or cashsettlementNumber of shares% of shares outstandingSwapCash Settlement8,000,000.003.875746%SUBTOTAL 8.B.28,000,000.003.875746%9. Information in relation to the person subject to the notification obligation (please mark theapplicable box with an "X")Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerFull chain of controlled undertakings through which the shares and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity(please add additional rows as necessary)XName% of shares outstanding if it equals or is higher than the notifiable threshold% of shares outstanding through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable thresholdMatthew HalbowerMCH PWCM Holdings Inc.Pentwater Capital Management LP3.875746%3.875746%10. Additional informationPlace of completionNaplesDate of completion05/06/2026SOURCE: Faron PharmaceuticalsView the original press release on ACCESS Newswire
Faron Pharmaceuticals LTD: Holding(s) in Company
TURKU, FI / ACCESS Newswire / June 8, 2026 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN)Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS1a. Identity of the issuer or the underlying issuer of existing shares:Faron Pharmaceuticals Oy1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)Non-UK issuerX2. Reason for the notification (please mark the appropriate box or boxes with an "X")An acquisition or disposal of sharesAn acquisition or disposal of financial instrumentsAn event changing the breakdown of shares outstandingXOther (please specify):3. Details of person subject to the notification obligationNamePentwater Capital Management LPCity and country of registered office (if applicable)Naples, United States4. Full name of shareholder(s) (if different from 3.)NameCity and country of registered office (if applicable)5. Date on which the threshold was crossed or reached:04/06/20266. Date on which issuer notified (DD/MM/YYYY):05/06/20267. Total positions of person(s) subject to the notification obligation% of shares outstanding (total of 8. A)% of shares outstanding through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of shares outstanding held in issuerResulting situation on the date on which threshold was crossed or reached3.875746%3.875746%8,000,000.00Position of previous notification (ifapplicable)4.342441%4.342441%8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedvA: SharesClass/type ofsharesISIN code (if possible)Number of shares outstanding% of shares outstandingDirect Indirect Direct Indirect SUBTOTAL 8. AB 1: Financial Instruments as an entitlement to acquireType of financial instrumentExpirationdateExercise/ Conversion PeriodNumber shares that may be acquired if the instrument isexercised/converted.% of shares outstandingSUBTOTAL 8. B 1B 2: Financial Instruments with similar economic effectType of financial instrumentExpirationdateExercise/ Conversion PeriodPhysical or cashsettlementNumber of shares% of shares outstandingSwapCash Settlement8,000,000.003.875746%SUBTOTAL 8.B.28,000,000.003.875746%9. Information in relation to the person subject to the notification obligation (please mark theapplicable box with an "X")Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerFull chain of controlled undertakings through which the shares and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity(please add additional rows as necessary)XName% of shares outstanding if it equals or is higher than the notifiable threshold% of shares outstanding through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable thresholdMatthew HalbowerMCH PWCM Holdings Inc.Pentwater Capital Management LP3.875746%3.875746%10. Additional informationPlace of completionNaplesDate of completion05/06/2026SOURCE: Faron PharmaceuticalsView the original press release on ACCESS Newswire
